DOI: 10.1055/s-00034926

Homeopathy

LinksClose Window

References

FDA.
Tysabri (natalizumab): update of healthcare professional information.
MedWatch: US Department of Health and Human Services; 2011 April 22. Available at:
http://www.fda.gov/Safety/MedWatch/SafetyInformation/SafetyAlertsforHumanMedicalProducts/ucm199965.htm.

Download Bibliographical Data

We do not assume any responsibility for the contents of the web pages of other providers.